Canada Markets close in 5 mins

Obalon Therapeutics, Inc. (OBLN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
0.8001+0.0506 (+6.75%)
As of 3:54PM EDT. Market open.

Obalon Therapeutics, Inc.

5421 Avenida Encinas
Suite F
Carlsbad, CA 92008-4410
United States
844 362 2566

IndustryMedical Devices
Full Time Employees34

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew P. RasdalCEO, Pres & Director325.99kN/A1958
Mr. Mark C. BristerChief Technology Officer403.49kN/A1962
Ms. Amy VandenBergChief Quality Assurance, Clinical & Regulatory Affairs Officer403.49kN/A1975
Dr. Kelly Huang Ph.D.Consultant479.82kN/A1969
Ms. Nooshin HussainyChief Financial OfficerN/AN/A1958
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.

Corporate Governance

Obalon Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.